Drugs / FRF-001
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07293546 | Apr 2026 → Mar 2029 expected | FOXG1 disorder | FOXG1 Research Foundation | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FRF-001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07293546 ↗ |
| Route | Other | “delivered by intracerebroventricular injection” NCT07293546 ↗ |